Kairos Pharma Ltd (AMEX:KAPA) shares, rose in value, with the stock price up by 5.80% to the previous day’s close as strong demand from buyers drove the stock to $0.96.
Actively observing the price movement in the last trading, the stock closed the session at $0.91, falling within a range of $0.9264 and $1.03. Referring to stock’s 52-week performance, its high was $4.00, and the low was $0.85. On the whole, KAPA has fluctuated by 2.13% over the past month.
With the market capitalization of Kairos Pharma Ltd currently standing at about $13.15 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-14.
The stock’s technical analysis shows that the price of KAPA currently trading nearly -1.43% and -11.85% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.30, while the 7-day volatility ratio is showing 10.42% which for the 30-day chart, stands at 12.67%. Furthermore, Kairos Pharma Ltd (KAPA)’s average true range (ATR) is 0.13.
Data on historical trading for Kairos Pharma Ltd (AMEX:KAPA) indicates that the trading volumes over the past 10 days have averaged 0.21 and over the past 3 months, they’ve averaged 405.12K. According to company’s latest data on outstanding shares, there are 13.74 million shares outstanding.
Nearly 57.51% of Kairos Pharma Ltd’s shares belong to company insiders and institutional investors own 0.26% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 20430.0 shares as on 2025-03-31, resulting in a short ratio of 0.26. According to the data, the short interest in Kairos Pharma Ltd (KAPA) stood at 29.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 30411.0. The stock has fallen by -36.84% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the KAPA stock heading into the next quarter.